Trial Search

Current Search Criteria:

Intervention: Recombinant Factor VIII (Kovaltry, BAY81-8973) Treatment Group 3
Found 1 matching trials

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

PHASE4

The goal of this study is to gather more information on safety and efficacy...

Status

Completed

Location

Beijing Children's Hospital, Capital Medical University

Start Date

2020-09-22

Trial ID

NCT04565236

Treatments Being Tested

Recombinant Factor VIII (Kovaltry, BAY81-8973) Treatment Group 1Recombinant Factor VIII (Kovaltry, BAY81-8973) Treatment Group 2Recombinant Factor VIII (Kovaltry, BAY81-8973) Treatment Group 3
PreviousNext